| |
MRSA
|
4MRGN
|
VRE
|
ESBL
|
|---|
| |
Universal screening *
|
Risk-based **
|
Only admission to critical wards
|
Not reported
|
Admission screening
|
|---|
|
Tertiary (n = 45)
|
2 (4.4 %)
|
35 (77.8 %)
|
4 (8.9 %)
|
4 (8.9 %)
|
30 (66.7 %)
|
19 (42.2 %)
|
15 (33.3 %)
|
|
Secondary (n = 76)
|
6 (7.9 %)
|
58 (76.3 %)
|
3 (3.9 %)
|
9 (11.8 %)
|
34 (44.7 %)
|
18 (23.7 %)
|
19 (25.0 %)
|
|
Primary (n = 208)
|
14 (6.7 %)
|
168 (80.8 %)
|
3 (1.4 %)
|
23 (11.1 %)
|
62 (29.8 %)
|
32 (15.4 %)
|
38 (18.3 %)
|
|
total (n = 329)
|
22 (6.7 %)
|
261 (79.3 %)
|
10 (3.0 %)
|
36 (10.9 %)
|
126 (38.3 %)
|
69 (21.0 %)
|
72 (21.9 %)
|
- * all admissions, ** according to KRINKO
